Neutralization of the γ-secretase activity by monoclonal antibody against extracellular domain of nicastrin
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neutralization of the γ-secretase activity by monoclonal antibody against extracellular domain of nicastrin
Authors
Keywords
-
Journal
ONCOGENE
Volume 31, Issue 6, Pages 787-798
Publisher
Springer Nature
Online
2011-07-05
DOI
10.1038/onc.2011.265
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Notch signaling: Emerging molecular targets for cancer therapy
- (2010) Ling Yin et al. BIOCHEMICAL PHARMACOLOGY
- Membrane rafts in Alzheimer's disease beta-amyloid production
- (2010) Kulandaivelu S. Vetrivel et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Biological and clinical implications of nicastrin expression in invasive breast cancer
- (2010) Aleksandra Filipović et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeting Notch to Target Cancer Stem Cells
- (2010) A. Pannuti et al. CLINICAL CANCER RESEARCH
- -Secretase Composed of PS1/Pen2/Aph1a Can Cleave Notch and Amyloid Precursor Protein in the Absence of Nicastrin
- (2010) G. Zhao et al. JOURNAL OF NEUROSCIENCE
- Therapeutic antibody targeting of individual Notch receptors
- (2010) Yan Wu et al. NATURE
- The secretases: enzymes with therapeutic potential in Alzheimer disease
- (2010) Bart De Strooper et al. Nature Reviews Neurology
- A conserved tetraspanin subfamily promotes Notch signaling in Caenorhabditis elegans and in human cells
- (2010) C. D. Dunn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Challenges in monoclonal antibody-based therapies
- (2009) Haritha Samaranayake et al. ANNALS OF MEDICINE
- Preclinical Profile of a Potent -Secretase Inhibitor Targeting Notch Signaling with In vivo Efficacy and Pharmacodynamic Properties
- (2009) L. Luistro et al. CANCER RESEARCH
- Dual antitumor mechanisms of Notch signaling inhibitor in a T-cell acute lymphoblastic leukemia xenograft model
- (2009) Shigeo Masuda et al. CANCER SCIENCE
- The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
- (2009) Raphael Kopan et al. CELL
- Secretase inhibitors and modulators for Alzheimer’s disease treatment
- (2009) Taisuke Tomita Expert Review of Neurotherapeutics
- Single Chain Variable Fragment against Nicastrin Inhibits the γ-Secretase Activity
- (2009) Ikuo Hayashi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Glu-333 of Nicastrin Directly Participates in γ-Secretase Activity
- (2009) Daniel R. Dries et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metalloprotease ADAM10 Is Required for Notch1 Site 2 Cleavage
- (2009) Geert van Tetering et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of γ-Secretase Activity by Helical β-Peptide Foldamers
- (2009) Yuki Imamura et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Analysis of the γ-secretase interactome and validation of its association with tetraspanin-enriched microdomains
- (2009) Tomoko Wakabayashi et al. NATURE CELL BIOLOGY
- The role of NOTCH1 signaling in T-ALL
- (2009) A. A. Ferrando Hematology-American Society of Hematology Education Program
- Glu332in the Nicastrin Ectodomain Is Essential for γ-Secretase Complex Maturation but Not for Its Activity
- (2008) Lucía Chávez-Gutiérrez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a γ-secretase inhibitor
- (2008) C Osipo et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search